Sales & Marketing

How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.

Sonam Dubey, a partner at Beghou Consulting, discusses the potential impact of a possible ban on direct-to-consumer advertising amid policy and government agency overhauls in the US.

The campaign also has a specific focus on Black Americans, who are more likely to develop the disease.

The campaign is launching alongside positive news for the company’s Phase 3 trials for a GBS treatment.

Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.

Marketing and sales personnel who leverage the expertise and insights of MedAffairs can often have better success.

Addressing key challenges in the modern sales sector requires a fundamental shift in training strategies.

Amy Hessels, Bayer‘s vice president of marketing, talks about how to engage younger demographics and how the Your Decision campaign contributes to broader conversations about women's reproductive autonomy and healthcare access.

The high-stakes nature of cancer care, coupled with rapid scientific advancements and increasing payer and regulatory pressures, demands a specialized approach beyond traditional market access strategies.

The two organizations will work together to promote healthy choices, such as early screenings.

Applying the McKinsey 7S Framework to TLL and regional marketing teams.

Market dynamics boost the need and urgency for more sophisticated benchmarking strategies.

eHealth’s latest survey reveals Americans give the nation’s healthcare system a low grade and are open to significant changes.

Heather Gervais, CEO of Osso VR, discusses how technological advancements in VR are solving problems for pharmaceutical sales reps.

March is Colorectal Cancer Awareness Month, and the health plan hopes to improve survival rates with early screenings.

A monthly roundup of business and people news in the pharmaceutical industry.

The actor is leading a campaign focused on joint pain.

In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer of Pleio, discusses the significant threat of misinformation to public health and how emotional appeal plays a part.

Anonymous reports claim the decision came from new leadership at HHS.

Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at scale while managing large territories and diverse customer bases.

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities.

The Blitz the Barriers initiative aims to reduce disparities among prostate cancer patients.

In this Q&A, Organon's Chief Communications Officer, Becky Edwards discusses how much social media and influencers sway decisions about birth control methods, potential consequences of these misinformed choices, and more.

How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.

The benefits for brand teams in bolstering their rapid-response capability.

In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies strategies pharmaceutical companies can use to combat misinformation on social media.

Naumovic discusses the impact that a lack of messaging can have a community.

In this Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, speaks about how distrust and uncertainty surrounding social media is impacting the pharmaceutical industry.

In this Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies how uncertainty of where to find information, coupled with distrust, can damage the relationship between pharmaceutical companies and the patients they aim to serve.

In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, explores the contributing factors growing distrust and uncertainty surrounding social media.